Psychedelics as medicines: an emerging new paradigm

Abstract

Scientific interest in serotonergic psychedelics (eg, psilocybin and LSD; 5‐HT2A receptor agonists) has dramatically increased within the last decade. Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in …